LBA11 Alectinib (ALC) vs crizotinib (CRZ) in Asian patients (pts) with treatment-naïve advanced ALK+ non-small cell lung cancer (NSCLC): 5-year update from the phase III ALESIA study

Chengcheng Zhou, Yidan Lu, S-W. Kim, T. Baisamut, Jianhui Zhou, Y. Zhang, J. He, Junpei Yang, Yufeng Cheng, SH Lee, J. Chang, J. Fang, Z. Liu, L. Bu, L. Qian, T. Xu, V. Archer, M. Hilton, M. Zhou, L. Zhang